New Zealand Passes Milestone E-cigarette Legislation

Oct.27.2022
New Zealand Passes Milestone E-cigarette Legislation
New Zealand's landmark e-cigarette legislation bans sales to under 18s and restricts use in public spaces.

On November 11, 2020, the "2020 Smokefree Environments and Regulated Products (Vaping) Amendment Act" came into effect in New Zealand. Two years later, New Zealand passed a landmark vaping legislation.


New Zealand's legislation and regulations may not be perfect, but they continue to set an example for other countries eager to combat tobacco. It's not the time to throw the baby out with the bathwater," said Nancy Lucas, co-founder of the New Zealand Vaping Advocacy Alliance.


The bill aims to ensure that smokers who want to switch to safer alternatives can use e-cigarette products and also ensure that these products are not sold or distributed to minors. It seeks to strike a balance between promoting the use of e-cigarettes for harm reduction and preventing their use among young people.


Ms. Lucas stated that while New Zealand continues to implement various industry regulations, the requirements that went into immediate effect two years ago have had a positive impact.


Starting from November 11th, 2020, the use of electronic cigarettes is prohibited in workplaces, schools, childcare centers, and other locations. Sales of electronic cigarette products to individuals under the age of 18, as well as all advertising and sponsorships related to electronic cigarette products, are also prohibited. "If youth e-cigarette use is a problem, the solution isn't changing the law, because it's already abundant. The solution lies in parental responsibility and greater enforcement by regulatory agencies. Those found selling e-cigarettes to minors may face severe penalties. Any rogue retailer now has to face the consequences, as they make good legislation look bad," Ms. Lucas said.


The New Zealand E-Cigarette Advocacy Group has stated that the title of the Ministry of Health's website on e-cigarettes being "less harmful than smoking" is also world-leading.


New Zealand is currently engaged in a public battle to achieve a smoke-free status by 2025, which would mean reducing smoking rates to 5% or below. In comparison, Australia's ban on selling safer nicotine products and scaremongering tactics with publicly-funded campaigns have had little impact in reducing smoking rates in recent years, according to a spokesperson. In order to further curb the appeal and availability of deadly tobacco, the Health Select Committee will deliver a report on amendments to create smoke-free environments and regulated products, including traditional tobacco, by December 1st.


Ms. Lucas stated that now is the time for a strict crackdown on tobacco, rather than re-prosecuting the electronic cigarette rules and regulations that were fiercely debated and scrutinized by parliament and health leaders. "Governments, politicians, and officials from around the world continue to study the work that New Zealand has done in reducing smoking rates and achieving a smoke-free goal. Maintaining its harm reduction approach to tobacco is how New Zealand will suppress tobacco and save thousands of lives each year," said Nancy Lucas.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's contents. The compilation of this article is intended solely for industry exchange and research.


Due to limitations in translation proficiency, the translated article may not fully express the content of the original piece. Please refer to the original article for accuracy.


2FIRSTS is in complete alignment with the Chinese government when it comes to any domestic, Hong Kong, Macau and Taiwan-related, or foreign positions and expressions.


The copyright of the compiled information belongs to the original media and author. If there is infringement, please contact us to request removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
According to Law360 on August 31, 2026, a federal judge in North Carolina ruled that a patent sublicense between R.J. Reynolds Vapor Co. and Juul Labs Inc. relieves Reynolds of its obligation to continue paying royalties to Altria Client Services LLC over Vuse Alto. A jury had previously found that Vuse Alto infringed three Altria patents and awarded approximately $95.2 million in past damages, after which Reynolds was ordered to pay an ongoing royalty equal to 5.25% of positive net sales. The new ruling finds that a valid sublicense can eliminate future infringement, potentially ending what Altria described as hundreds of millions of dollars in future royalties.
Sep.01
 $20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
$20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
An Illinois court ordered three companies tied to Posh vapes to pay $20 million and permanently restricted the sale, marketing and distribution in Illinois of products lacking required FDA authorization. The consent order also imposes downstream distributor controls, age-verification measures and social-media marketing limits, creating a new state-level compliance benchmark for disposable vape businesses.
Regulations
Aug.05
PMI Expands IQOS and VEEV Presence at Frankfurt Airport Through Travel Retail Pop-Ups
PMI Expands IQOS and VEEV Presence at Frankfurt Airport Through Travel Retail Pop-Ups
According to The Moodie Davitt Report, PMI Global Travel Retail and Frankfurt Airport Retail have launched new IQOS and VEEV retail spaces at Frankfurt Airport. The installations, located inside and outside duty-free areas, showcase IQOS heated tobacco products and VEEV e-vapor products through product education, consumer interaction and brand experiences. Frankfurt Airport Retail, operated by Fraport Group and Gebr. Heinemann, manages key retail activities at Frankfurt Airport. The initiative follows PMI’s broader strategy of expanding smoke-free products through global travel retail channels. PMI has previously introduced VEEV products across multiple European airports while continuing to expand IQOS and VEEV availability in international markets.
Jul.17
Product | IVG Pro 15K Enters European Retail Channels, Expanding High-Capacity Pod System Segment
Product | IVG Pro 15K Enters European Retail Channels, Expanding High-Capacity Pod System Segment
UK vape brand IVG has introduced the IVG Pro 15K, a high-capacity pod system combining a 2ml prefilled pod with a 10ml refill container to deliver up to 15,000 puffs. Unlike conventional high-puff disposable vapes, the IVG Pro 15K adopts a reusable device structure, reflecting a broader shift in the European vape market toward longer-use-cycle products and reusable hardware ecosystems.
Jul.14
U.S. Appeals Court Says BAT Must Face Class Action Over Cigarette Labels
U.S. Appeals Court Says BAT Must Face Class Action Over Cigarette Labels
A U.S. appeals court ruled that British American Tobacco (BAT) must continue facing a consumer class action lawsuit over cigarette labels. The ruling allows the case to proceed but does not determine that BAT violated the law or is liable for damages. The case highlights ongoing legal risks facing major tobacco companies related to product labeling, consumer disclosures and product liability claims.
Jul.31
BAT Regional Director Fred Monteiro Supports Spain’s Nicotine Rules but Opposes 0.99mg Nicotine Pouch Limit
BAT Regional Director Fred Monteiro Supports Spain’s Nicotine Rules but Opposes 0.99mg Nicotine Pouch Limit
Spanish newspaper El Confidencial interviewed Fred Monteiro, Regional Director for Americas and Europe at British American Tobacco (BAT). Monteiro said BAT supports setting regulatory limits for nicotine products but opposes Spain’s proposed 0.99mg nicotine-per-pouch limit, arguing that such a restriction could affect adult smokers’ transition to alternatives. He said nicotine regulation should be based on scientific evidence and harm reduction principles. Monteiro also said smoke-free products now account for around 25% of BAT’s Americas and Europe business and nearly 30% of its Europe business
BAT
Jul.30